Newsroom
Your source for Evernorth news.
Evernorth announces another step forward in lowering drug prices by making a Stelara biosimilar available at $0 out of pocket for patients early next year
Estimated to save individual Accredo patients around $4,000 per year
Biosimilar price will be more than 80% lower than Stelara list price
Accredo patients benefit from the specialty pharmacy’s best-in-class clinical support
Close search filters
Changing filters will change the listed Success Criteria and Techniques
Search results (50)
Press Release
Evernorth Names Tony Colistra New President of MD Live, Evernorth Workplace Care
September 04, 2024
Press Release
Express Scripts by Evernorth Members Paid Less for Their Share of Prescriptions in 2023 Despite Drug Price Increases
June 19, 2024
Members with employer-sponsored insurance saw about a 1% decrease in their portion out-of-pocket costs for their prescription medicines last year, paying an average of $15.10 for a 30-day supply
Press Release
Express Scripts enhances strategies to support access to care at independent pharmacies
May 23, 2024
Based on guidance from its Independent Pharmacy Advisory Committee, Express Scripts will collaborate with CPESN ® USA through its IndependentRx initiative.
Press Release
Evernorth announces Humira biosimilar available at $0 out of pocket for Accredo patients in June
April 25, 2024
Press Release
Evernorth’s New Behavioral Care Practice Offers Quality Care To Improve Mental Well-Being
March 07, 2024
Evernorth is launching an outpatient behavioral health practice to expand access to quality, in-network therapy for millions of people.
Press Release
Evernorth Announces Industry-First Financial Guarantee For GLP-1 Spend
March 07, 2024
EncircleRx solution now includes financial predictability for health plan sponsors to help expand access for appropriate patients.